Visa Inc.'s growth in revenue & profitability showcases strength in payment processing. See why its high valuation keeps it ...

President Trump announced reciprocal tariffs on 185 nations, causing a significant market downturn and panic selling, with a ...

Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...

AMS Q4 2024 earnings highlight 59% revenue growth, international expansion, and patient-centric strategy. Learn about future opportunities and challenges.

Good day and welcome to the American Shared Hospital Services Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s ...

China trade war. Learn strategies for investing during downturns & potential recovery scenarios. Click for more.

Nike's stock sees a 24% dip amid tariff challenges and weak Q4 metrics. Click here to read an analysis of NKE stock now.

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

Silver, while volatile and heavily used in industry, serves as a proxy for gold, especially during fear trades. Expert Don ...

RBC cuts its 2025 S&P target by 11% to 5,550, seeing a growth scare rising amid Trump tariffs. Read more here.

The yardstick of fear among investors, the CBOE Volatility Index, surged past 28 on Thursday, well above its 10-year average.